English | Español

Community
+ Community
Carol Ostrow | Oct 22, 2017

Quadruple amputee proves power of rehabilitation at Wake Forest Baptist
+ Community
Marian Johns | Oct 22, 2017

Wake Forest Baptist receives $9.2 million National Cancer Institute grant
+ Regulatory
Marian Johns | Oct 22, 2017

FDA grants fast-track status to Astellas' acute myeloid leukemia drug
+ Community
Kathy Adams | Oct 22, 2017

Amgen, Boston Children's Hospital team up for study on unusual pain response
+ Technology/Innovation
Carol Ostrow | Oct 22, 2017

NIAID, Caltech researchers consider development of universal flu vaccine in report
+ Technology/Innovation
Marian Johns | Oct 21, 2017

Study: Women with gestational diabetes can reduce heart disease risk with healthy lifestyle
+ Community
Marian Johns | Oct 21, 2017

Eli Lilly announces fourth-quarter dividend
+ Regulatory
Kathy Adams | Oct 20, 2017

Hargan declares public health emergency in California

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'